Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

The Economic Burden of Acute Myeloid Leukemia in Iran

Sat Apr 20 14:11:34 2024

(2022) The Economic Burden of Acute Myeloid Leukemia in Iran. Iranian Journal of Public Health. pp. 2599-2607. ISSN 2251-6085

Full text not available from this repository.

Official URL: <Go to ISI>://WOS:000885980400023

Abstract

Background: Cancer imposes a significant economic burden on the health system and society. Acute myeloid leukemia (AML) is the third deadliest leukemia and is one of the leading health problems worldwide. The pre-sent study aimed to estimate the economic burden of AML in Iran for 2020.Methods: In this study, we estimated a prevalence-based on the cost-of-illness of the AML in Iran. A societal perspective was considered, in which the direct costs and productivity losses with the adoption of the human capital approach in the AML cases were estimated for 2020. Moreover, in the present study, several resources including national cancer registry reports, hospital records, occupational data, and interviews with experts were cited.Results: Approximately 98 of patients with AML received induction therapy. The AML economic burden was 33,243,107.39. Indirect costs accounted for 60 (21,593,764.4) of this amount, and direct medical costs and direct non-medical costs make up for 19 (6,359,380.88) and 16 (5,289,962.11) of this estimated eco-nomic burden, respectivelyConclusion: The economic burden of AML in Iran is very remarkable and due to the increasing prevalence of this disease, it is expected to increase gradually. Having insights into the costs associated with the disease pro-vide an excellent opportunity for health policymakers and managers to effectively improve resource allocation.

Item Type: Article
Creators:
CreatorsEmail
Alipour, V.UNSPECIFIED
Rad, S.UNSPECIFIED
Nargesi, S.UNSPECIFIED
Mezginejad, F.UNSPECIFIED
Jahangiri, R.UNSPECIFIED
Dolatshahi, Z.UNSPECIFIED
Mousavi, S. A.UNSPECIFIED
Moshkard, Z.UNSPECIFIED
Keywords: Acute myeloid leukemia Consolidation therapy Iran Economic burden cost-of-illness risk-stratification cancer update care Public, Environmental & Occupational Health
Divisions:
Page Range: pp. 2599-2607
Journal or Publication Title: Iranian Journal of Public Health
Journal Index: ISI
Volume: 51
Number: 11
ISSN: 2251-6085
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/4206

Actions (login required)

View Item View Item